Automatic Google Translation of entire article:
4 February 2023 by Victor Ingrassia
Las nuevas formulaciones que incluyen el virus original y la variante Ómicron BA.4 y BA.5 ya se dan en la Argentina. ¿Por qué son más efectivas? ¿En qué distritos se aplican? ¿Cómo definirán el futuro de la pandemia?
www-infobae-com.translate.goog
Application in ARG, effectiveness and safety: the keys to bivalent vaccines against COVID. The new formulations that include the original virus and the Omicron BA.4 and BA.5 variant are already in use in Argentina. Why are they more effective?
...
.They are already available in ARG: in which places?
The National Ministry of Health announced on January 24 the arrival of bivalent boosters in our country: Original Bivariate Comirnaty/Ómicron BA.4-5, from Pfizer-BioNTech, and Original Bivariate Spikevax/Ómicron BA.4-5, from Moderna, which the next day began to be applied in some districts such as City of BA and Mendoza....
....
Who can receive it?
The bivalent vaccines that arrived in the country are Original Bivariate Comirnaty/Omicron BA.4-5 from the Pfizer/BioNtech laboratory. There are 1,100,160 doses that are applied to the general population of 12 years or older. In the second week of February, 3 million more doses of Moderna's Spikevax Bivariate Original/Omicron BA.4-5 vaccine are expected to arrive in the country (which can be administered to people 6 years of age or older), and another 1.2 million of the Pfizer dose.
It can be received by all people over the age of 12 (Pfizer) and over the age of 6 (Moderna), who have received a monovalent vaccine (primary or booster scheme) 4 months or more ago. Like the other doses, the minimum interval of four months from the last dose received must be maintained....
UPDATE:
Información sobre las vacunas que estamos aplicando en la Ciudad recibidas por el Gobierno Nacional.
buenosaires.gob.ar
General Population and inmunosuppresed patients....booster: Pfizer Bivalent
This morning I went to Club San Lorenzo (with appt) to receive the bivalent booster shot. I was told I did not qualify because I am not an
inmunosuppresed individual even though that is not what it says on the CABA website.
I spoke with the clinic supervisor:
1. In CABA, they have yet to receive authorization from the National Ministry of Health to inoculate the
general population with the Pfizer bivalent booster.
2. The bivalent booster from Moderna has yet to arrive in ARG.
Just as well for me because I prefer to be inoculated with the Moderna bivalent booster. I will get that shot during the first week in April when I am scheduled to arrive in San Francisco.